Bilibili Inc. (BILI)

Theseus Pharmaceuticals Revenue

Bilibili had revenue of 7.00B CNY in the quarter ending March 31, 2025, with 23.63% growth. This brings the company's revenue in the last twelve months to 28.17B, up 21.83% year-over-year. In the year 2024, Bilibili had annual revenue of 26.83B with 19.10% growth.

• Revenue (ttm): 28.17B CNY
• Revenue Growth: +21.83%
• P/S Ratio: 2.47
• Revenue / Employee: 3,482,959 CNY
• Employees: 8,088
• Market Cap: 9.41B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	26.83B	4.30B	19.10%
Dec 31, 2023	22.53B	628.82M	2.87%
Dec 31, 2022	21.90B	2.52B	12.98%
Dec 31, 2021	19.38B	7.38B	61.54%
Dec 31, 2020	12.00B	5.22B	77.03%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.